Galapagos NV said that it has expanded a risk-sharing deal with Roche aimed at discovering new therapies against chronic obstructive pulmonary disease (COPD) to increase the number of targets for antibody drugs. The deal dates from January 2010. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
